Selectis HealthGBCS -0.58%47 Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus rates GBCS with a GF Score™ of 47/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Selectis Health ranks worse than 363636% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Selectis Health's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GBCS vs CCM, BMGL, AMS: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Selectis Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selectis Health Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Selectis Health's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health (GBCS) has a Buyback Yield % of 0.00 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Selectis Health and its competitors. According to the industry distribution chart, Selectis Health ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is Selectis Health's Buyback Yield % too high?
Selectis Health's current Buyback Yield % is 0.00. Based on the distribution chart, Selectis Health ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Selectis Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's Buyback Yield % compare to CCM and BMGL?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #999999 out of 275 companies for Buyback Yield %. This places Selectis Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Selectis Health and its competitors. Selectis Health's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.18 — trading 142.1% above its estimated fair value. The current Buyback Yield % is 0.00. Selectis Health's overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Selectis Health (GBCS), the current Buyback Yield % is 0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selectis Health (GBCS) Overvalued in 2026?
Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued.
The current stock price of $5.18 is trading 142.1% above its estimated GF Value™ of $2.14.
GuruFocus considers Selectis Health to be Significantly Overvalued.
Key valuation signals for GBCS:
Buyback Yield %: 0.00
GF Value™: $2.14 vs. price of $5.18 (142.1% above fair value)
No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
47GF Score
Get the complete analysis for GBCS
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GBCS has been successfully added to your 
